Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
New Engl J Med (2012) 36617:156776
Ready to stop guessing and start losing
GLP-1 clinics vary widely in how they balance cost, oversight, and support
Three quarters of patients managed with pasireotide require other medication for glucose management
Accessed May 2, 2026
Known as the incretin effect, GLP-1 and its synergetic sister hormone glucose-dependent insulinotropic polypeptide (GIP), are rapidly released by lower enteroendocrine L-cells (GLP-1) or upper enteroendocrine K-cells (GIP) in the gut following food intake and rising circulatory glucose levels to augment the glucose-stimulated release of insulin by pancreatic cells
US$ 20.00
US$ 24.05
US$ 23.77
US$ 25.48
US$ 23.13
US$ 20.92
US$ 22.02
US$ 22.00
